Amsacrine

AMSA; AMSA P-D; Amsacrina; Amsidine; Amsidyl; Cain's Acridine; Gödecke Brand of Amsacrine; NSC-141549; NSC-156303; NSC-249992; Parke Davis Brand of Amsacrine; Parke Davis Brand of Amsacrine Lactate; SN-11841; SN11841; meta-AMSA; AMSA P D; AMSA PD
Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.